OQ Chemicals to Build Methyl Methacrylate Plant in Bay City, TX
26 Jul 2022
OQ Chemicals signed a final investment decision (FID) to build additional capacity of propionic aldehyde as well as infrastructure. This is to support Röhm, one of the leading methacrylate producers, in constructing a world-scale methyl methacrylate (MMA) plant at an OQ Chemicals’ production site.
The new MMA plant has a design capacity of 250,000 tons per year and will utilize Röhms’ latest proprietary LiMA technology. OQ Chemicals will integrate the plant into its production site at Bay City, TX, and provide raw materials, utilities, and site services to Röhm. In 2021 both companies signed a Memorandum of Understanding in this regard. Based on the engineering progress of both parties, all other arrangements for construction are now complete. The new plant is slated to be mechanically complete by Q1 2024.
"This project goes by ‘Propel’, which is short for ‘Propyls Elevated’. We are excited to have achieved FID on Propel and can move ahead as planned. At OQ Chemicals, we are looking forward to welcoming Röhm to our site in Bay City. I am convinced that both companies will greatly benefit from our future cooperation and combined expertise," said Dr. Oliver Borgmeier, CEO of OQ Chemicals.
“We are very pleased to see the developments and to reach this important milestone,” said Ron Ayles, managing partner at Röhm’s financial sponsor Advent International. “LiMA will significantly strengthen Röhm’s position in the MMA market.”
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.